February 19, 2019, 1:26 pm Baltimore
The University of Maryland BioPark company’s candidate drug is being developed to treat a rare neurological disorder.
By Stephen Babcock
Technical Delivery Manager
See more jobs from the Technical.ly Community See all jobs
Sr. Full Stack Developer
QA Automation Engineer
Sign-up for daily news updates from Technical.ly
V. 3.4.0 February 10, 2019 / © 2019 Technically Media Inc. All Rights Reserved.